Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,905,584
-$16,930,607 QoQ
Shares Held
123,187
-80.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#192
of 1,348 holders
Holding Since
Dec 2020
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Jump Financial, LLC holds $60,679,237 across 7 Drug Manufacturers - General names. NVO ranks #3 (9.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
30,924 | $37,091,175 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
88,471 | $11,177,425 | |
| 3 | NVO |
Novo Nordisk A S
This page
|
123,187 | $5,905,584 | |
| 4 | JNJ |
Johnson & Johnson
|
14,450 | $3,669,866 | |
| 5 | ABBV |
AbbVie Inc.
|
9,600 | $2,415,743 | |
| 6 | PFE |
Pfizer Inc
|
9,470 | $228,037 | |
| 7 | AMRN |
Amarin Corp Plc\Uk
|
12,008 | $191,407 |
All Filings in NVO
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,905,584 | 123,187 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $22,836,191 | 621,393 | Shares | Defined | 2026-05-14 | |
| 2025-09-30 | $1,203,355 | 21,686 | Shares | Defined | 2025-11-13 | |
| 2025-03-31 | $340,255 | 4,900 | Shares | Defined | 2025-05-14 | |
| 2024-09-30 | $202,180 | 1,698 | Shares | Defined | 2024-11-14 | |
| 2023-12-31 | $448,662 | 4,337 | Shares | Sole | 2024-10-21 | |
| 2023-09-30 | $387,494 | 4,261 | Shares | Sole | 2024-10-21 | |
| 2023-03-31 | $726,314 | 4,564 | Shares | Sole | 2024-10-21 | |
| 2021-03-31 | $243,588 | 3,613 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $440,543 | 6,307 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||